Chris Prowse

Research & Development Director, Scottish National Blood Transfusion Service, United Kingdom

Chris Prowse

Academic positions:
- Research & Development Director, Scottish National Blood Transfusion Service

All industry positions (in last five years):

Research interests:
Dr Prowse's current interests are in the fields of vCJD, Blood Components, Pathogen Inactivation, Transfusion Transmitted Infection, Cell Therapy, Immunohaematology and the Effective Use of Blood.

Any other information:

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Hematology > Hematologic Transplantation & Transfusion (since 11 November 2005)

All recent recommendations

• 3.0
  Bcl-2 family proteins are essential for platelet survival.
  Recommended by Chris Prowse
  
• 6.4
  The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
  Recommended by Chris Prowse, Neil Blumberg
  
• 6.0
  Bacterial glycosidases for the production of universal red blood cells.
  Recommended by Chris Prowse
  
• 3.0
  Benefits of a blood donation archive repository: international survey of donor repository procedures and Scottish experiences.
  Recommended by Chris Prowse
  
• 6.0
  Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study.
  Recommended by Chris Prowse
  
• 9.6
  Programmed anuclear cell death delimits platelet life span.
  Recommended by Neil Kaplowitz, Chris Prowse
  
• 3.0
  Profiling of alterations in platelet proteins during storage of platelet concentrates.
  Recommended by Chris Prowse
  
• 3.0
  Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide.
  Recommended by Chris Prowse
  
• 6.0
  Presymptomatic detection of prions in blood.
  Recommended by Chris Prowse
  
• 6.0
  Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.
  Recommended by Chris Prowse
  
• 3.0
  Prion-induced amyloid heart disease with high blood infectivity in transgenic mice.
  Recommended by Chris Prowse
  
• 3.0
  Assessment of the economic value of the INTERCEPT blood system in Belgium.
  Recommended by Chris Prowse
  
• 6.9
  The risk associated with aprotinin in cardiac surgery.
  Recommended by Andrew Davenport, Manfred Seeberger, Anneke Brand, Philippe de Moerloose, Chris Prowse
  Dissent by Neil Blumberg
• 3.0
  Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.
  Recommended by Chris Prowse